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Effects of Puff-Adder Venom on Coagulation,
Fibrinolysis and Platelet Aggregation in the
Baboon
S. BRINK,
SUMMARY
The in vitro and in vivo haematological effects of puff-
adder (Bitis arietans) venom in the baboon (Papio ursinus)
with regard to its effect on coagulation, fibrinolysis and
platelet aggregation were studied. There is a delay in the
intrinsic coagulation mechanism with fibrinolysis and
in vitro fibrinogenolysis. Normal human platelets demon-
strated an extreme susceptibility to puff-adder venom
in vitro. The aggregation of platelets with small dosages
of venom was irreversible.
The effect is related to the dosage, and appears to be
the result of multiple enzyme activities, some of which are
heat-labile. In minimal amounts there is evidence of con-
sumption of blood coagulation factors with sustained
thrombocytopenia, but no fibrinolysis, where heparin
therapy might have a beneficial effect. With larger dosages
of venom the thrombocytopenia, haemorrhagic effects
and shock are not prevented or corrected by heparin and
heparinisation might even be harmful.
The effect of heparin should be further investigated,
since it might have a place in mildly affected cases of
snakebite, where absorption into the blood has been slow
or intermittent. It might be indicated when antivenene is
not available or when patients are sensitive to serum.
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coagulation, fibrinolysis and platelet aggregation in the
baboon. Special attention was given to the use of heparin
as part of the treatment.
MATERIALS AND METHODS
Venom
Lyophilised Bitis m'iuans venom was obtained from
Professor G. R. Delpierre, Department of Chemistry,
University College of the Western Cape. The venom was
reconstituted in 0,9% sterile saline just before use.
Baboons
Unconditione.d male or female baboons weighing 10-
15 kg were used. They were sedated with Sernylan 12 mg
initially, and lightly anaesthetised with intravenous
Veterinary Nembutal during the course of the experiments.
Cut-downs on both femoral arteries were done and T-
tubes inserted; one connected to a manometer measuring
the blood pressure and pulse rate, and the other used for
taking arterial blood samples. A slow intravenous saline
drip was used for injecting Nembutal and various con-
centrations of venom. An indwelling catheter was placed
in the bladder and the output of urine measured.
The puff-adder has been shown to be responsible for most
fatal snakebites in the Cape Province.] It belongs to' the
erectile-fanged group of snakes, and its fangs are relatively
long (10 - 15 mm), recurved and needle-sharp, with the
orifice for the discharge of the venom near the tip; they
are mounted right at the front of the upper jaw and can
be rotated through 90 0 to ensure that the venom is injected
sufficiently deep into the tissues.'
Recent reports indicate that disseminated intravascular
coagulopathy (DIC) may be the underlying mode of action
of many snakes' venoms.' Puff-adder venom has not been
investigated in this respect. This is a preliminary report
on the in vitro and in vivo effects of puff-adder venom on
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Laboratory Studies
Standard techniques were used. Full blood counts were
done with the Coulter Model S, and platelet counts were
done with the Coulter Model F. Blood smears were stained
with May-Griinewald-Giemsa. Clottable plasma fibrino-
gen concentrations were measured by a modification of
Ratnoff and Menzie's method.' Partial thromboplastin
time (PTT), prothrombin index (PI) and thrombin time
were done according to the method of Dacie and Lewis:
Prothrombin activity (PA) was done according to Owren's
method.' Tanned red cell haemagglutination inhibition
immunoassay (TRCHIIA) was done by the method of
Merskey et al.' Euglobulin lysis time was done as described
by Thompson: The fibrin plate lysis method used was
slightly modified from Ygge et al: The platelet aggregation
studies were done as described by Thompson s
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RESULTS Coagulation Studies in vitro
PI.t.l.t lllr.,.lit.
Clottable fibrinogen PIT, PI and PA were performed in
the presence of varying concentrations of venom with two
control tests without venom (Fig.2).
Large doses of venom: The most striking effect was on
the clottable fibrinogen concentration and the PIT; the
plasma becoming incoagulable in these two tests in the
presence of large doses of venom. The PI and PA were
slightly prolonged. The intrinsic coagulation mechanism is
thus particularly susceptible to venom. The last column in
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This was carried out as described by MacKay ef al. l •
(Fig. I).
Incubation of Venom with Purified Fibrinogen
Fig. 1. In vitro incubation of venom ~ith purified fibrino-
gen-see text. Upper graphs: Undenatured venom and
fibrinogen. Middle graphs: Heat denatured venom and
fibrinogen. Lower graphs: Control of saline and fibrinogen.
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After protein precipitation the supernatant demonstrated
a progressive increase of optical density at 280 A and pro-
longed thrombin time, with complete incoagulability of
the test after 24 hours. Two fractions of venom were
noticed with heat-stable fibrinogenolytic effects in vifro.
12345678
Fig. 3. Platelet aggregation studies in vitro_e text. The
effect of ADP upon platelet aggregation served as a
control.
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Fig. 2. Coagulation studies in vitro-see text.
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Fig. 7 demonstrates the results of the coagulation studies
after denaturation of the venom at 56"C for one hour.
Platelet Aggregation Studies
One-tenth millilitre of venom was added to I ml normal
human platelets, concentrated to 300 OOO/mm' in each test.
Venom in a concentration of 100 fLg/ml caused almost
complete aggregation within 5 minutes; venom in a con-
centration of 50 fLg/ml caused complete aggregation in 7
minutes, and venom in concentration of 30 fLg/ml had no
effect.
Studies on Baboons
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Fig. 4. Baboon 1 receiced 50 mg venom.
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Seven experiments were done.
Experiment 1 - baboons 1 and 2 received 50 mg venom:
Both animals died within 45 minutes, with dramatic
thrombocytopenia and severe fibrinolysis and very
markedly elevated TRCHIIA (Fig. 4).
Experiment 2 - baboons 3 and 4 received 10 mg venom
(Fig. 5): Severe fibrinolysis could be demonstrated by
elevated TRCHIIA, prolonged thrombin time and in-
creased fibrin plate lysis. The euglobulin lysis time was
greatly prolonged as a result of the afibrinogenaemia with
poor-quality clot formation. There was a dramatic, sus-
tained fall in platelet count within 5 minutes, and the PIT
became greatly prolonged. The haemoglobin and haema-
tocrit levels fell rapidly, and one baboon died after about
2 hours, and the other after about 4 hours.
Experiment 3 - baboon 5 received 10 mg venom with
500 units of heparin stat, followed by 150 units every hour
(Fig. 6): The same clinical picture as in the previous ex-
periments was seen. Anuria developed after 40 minutes and
the baboon died soon afterwards.
Autopsy reports on these 5 animals demonstrated the
extreme susceptibility of the loose tissues of the gastro-
intestinal tract, with macroscopical and microscopical
evidence of severe haemorrhage forming vascular lakes.
There was no histological evidence of micro-clot forma-
tion and no microscopical aggregation of platelets in the
blood vessels.
Experiment 4 - baboons 6, 7 and 8 received 100 fLg,
200 fLg and 500 fLg of venom respectively (Fig. 7): Relative-
ly few changes were noted, but there was a moderately
prolonged PIT, and after the 500-f-lg dose hypofibrinogcn-
aemia developed. The platelet count fell from 300000/mm3
to l50000/mm' within 5 minutes. Fibrin plate lysis and
TRCHIIA remained within normal limits.
Experiment 5 - baboon 9 received 1 mg of venom
(Fig. 8): There was a moderate, immediate fall in blood
pressure with a raised pulse rate. A fall in blood coagula-
tion factors with a prolonged PIT, a reduced PA and PI
and a fall in fibrinogen level were seen. but there was no
evidence of fibrinolysis as tested by TRCHIIA, fibrin
plate lysis and thrombin time. The platelet count fell
within 5 minutes and remained low for at least 24 hours.
This baboon developed moderately severe mucous mem-
brane haemorrhages and haematuria.
Control animals - baboon 10 was anaesthetised and
cut-downs were done on both femoral arteries. It was
monitored in a similar fashion to the test animals and
t
\
•
\
.
\
\
I
I
1- -- _••
•.,......._, r'-'-
., . . \
I ~ \I"".
_.-... \
. .
~ \
~ e
•
•
e.
.........~ .....
.. ..... .-.
., ......
Time
TRCHIIA
4
7
o
8
2
1208
LCM 60
S.A. MEDICAL JOURNAL
(Supplement-SoUlh Africa/! Journal of Laboratory and Clinical Medicine)
12 June 1974
received only a few millilitres of saline. The haematologi-
cal studies were all satisfactory.
Baboon 11 (Fig. 9): This baboon received heparin in a
dose sufficient to prolong the clotting time from 2±
minutes to 45 minutes, returning to normal within 6 hours.
normal after 6 hours, and 24 hours later routine studies
were within normal limits. There was no evidence of
mucous membrane haemorrhages or haematuria.
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Fig. 6. Baboon 6 received 10 mg venom with heparin as
indicated.
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Fig. 5. Baboon 3 received 10 mg venom.
Experiment 6 - baboon 12 received 1 mg venom with
3 000 units of heparin as a single dose (Fig. IQ): The
baboon remained in a good clinical condition with no
evidence of shock. The whole blood clotting time became
Experiment 7 - baboon 13 received 5 mg of venom
and heparin 2500 units 20 min after the venom (Fig. 11):
There was a dramatic thrombocytopenia within 5 minutes
and the fibrinogen level fell moderately. The thrombin
time increased from 12 seconds to 25 seconds within 20
minutes, whereas the PIT, PA and PI showed no signifi-
cant change within 20 minutes.
T
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Fig. 7. Baboon 8 receved 500 p.g venom.
Baboon 14 received 5 mg of venom and heparin 2500
units immediately after the venom (Fig. 12): In both
animals the blood became completely incoagulable after
the heparin administration, and both went into a severely
shocked state, developing bleeding gums and later exten-
sive subcutaneous haemorrhages. They died within 4t
hours in a state of exsanguination. The dramatic throm-
bocytopenia was not prevented or corrected by heparin.
They both developed haematuria and anuria. Schurnm's
test for methaem-albuminaemia was negative and there
were no blood pigments in the urine.
With the fibrin plate lysis method increasingly severe
fibrinolysis was demonstrated after the heparin adminis-
tration. TRCHIIA tests were negative throughout the serum
as well as the urine specimens.
DISCUSSION
The in vitro and in vivo haematological effects of the
venom in the baboon with regard to its effect on coagula-
tion. fibrinolysis and fibrinogenolysis were studied. It was
also demonstrated that normal platelets are extremely
sensitive to small doses of venom with irreversible aggre-
gation occurring very rapidly.
Coagulation Studies in vitro
Fibrinogenolysis: On incubation of the venom with
purified fibrinogen over 24 hours the thrombin clotting time
was prolonged. This was associated with the digestion of
fibrinogen as evidenced by the increased optical density
at 280 A, with incoagulability after 24 hours. The defective
clotting was probably largely due to breakdown products
of fibrinogen interfering with fibrin polymerisation. A
large fraction of the enzymatic activity of the venom
appeared to be heat-stable (56°C for 1 hour), but a small
heat-labile fraction was also present. This should be
further investigated.
Coagulation studies: The mode of action was primarily
on the intrinsic blood coagulation mechanism, as evidenced
by a prolonged PIT and clottable fibrinogen test with
the PA and PI only moderately prolonged. It was again
demonstrated that the greatest proportion of the venom is
heat-stable, but there was a small heat-labile fraction as
well.
Denaturation in relation to known enzymes: The
lyophilised snake venom used in our experiments con-
tained 77°~ soluble protein. Delpierren ." studied the
chemical and enzymatic properties of three venoms. All
three venoms tested (Bitis arietans, Bitis gabonica and
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Fig. 8. Baboon 9 received 1 mg venom.
Cal/SlIS rhembearus) were found to be active in catalysing
the hydrolysis of casein and urea-denatured haemoglobin,
with the puff-adder venom the most active, with an opti-
mal pH of 10. Proteolytic and amino acid esterase enzyme
activities can be separated by means of exchange and gel
filtration chromatography. A considerable body of evi-
dence exists to suggest that proteolytic activities are linked
to the blood coagulation, the haemorrhagic effects and the
severe necrotic lesions associated with the erectile-fanged
snakes. i "
The three major protease activites (A, Band C) from
puff-adder venom were further separated by Van der Wait
and ]oubert13 by gradient elution from CM-cellulose, and
protease A was further purified by Sephadex G-75 gel
filtration. It was found to have a molecular weight 'of
21 400 and it showed a tendency to undergo association,
particularly at higher concentrations., The .change in
apparent molecular weight of protease A with decreasing
concentration suggests a system of macromolecules which
dissociate on dilution. Protease with a narrow specificity
is of great value in the amino acid sequence determina-
tions of proteins, but the protease A fraction of puff-adder
venom was found to have a broad specificity, attacking
mainly the amino end of hydrophobic amino acid resi-
dues.H, i6
Other venoms: Tu eT al."'" undertook a systematic study
of a wide variety of snake venoms, and reported on
proteolytic, esterolytic, trypsin inhibitors, thrombin-like,
trypsin-like, chymotrypsin-like and acetylcholinesterase-like
enzymes.
Recently, with the hydrolysis of synthetic substrates, it
has been shown that the proteolytic enzyme present in
Crotalidae and Viper idea venoms is neither' trypsin nor
thrombin."·"
Platelet Aggregation Studies
Normal human platelets (platelet-rich plasma) demon-
stated an extreme susceptibility to puff·adder venom. -It
seems as if puff-adder venom has a direct irreversible
aggregating effect on human platelets, probably through
ADP.
This aggregating effect of the venom was dose-related
and was again demonstrated during the in vivo studies.
All the animals given a dose above I mg demonstrated
r
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Fig. 9. Baboon 11 served as heparin control and received no venom.
a dramatic thrombocytopenia within 5 minutes, and this
was sustained for at least 24 hours. This effect could not
be prevented by the use of heparin in vivo.
In vivo Studies on Baboons
Massive dose: In normal adult baboons minute quanti-
ties of puff-adder venom caused severe shock and rapid
death. All the animals given a dose of over 5 mg of
venom showed a dramatic thrombocytopenia within 5
minutes and a fall in plasma fibrinogen. With a dose of
50 mg of venom fibrinolysis could be demonstrated and
the blood became incoagulable. At autopsy there were
extensive haemorrhages. particularly into the mucosa of the
gastro-intestinal tract, but no evidence of microscopic
thrombi formation. Failure to detect intravascular clots in
envenomed humans and animals cannot be used as an
argument against intravascular clotting. since it has been
well documented that the clots may be dissolved ante- or
postmortem by a fibrinolytic mechanism."'" The rapid
death of the animals was due to severe internal haemorr-
hage.
Smaller dose: The most prominent effect again appeared
to be on the intrinsic coagulation mechanism, with hypo-
fibrinogenaemia and transient thrombocytopenia. There
was no evidence of fibrinolysis and it was unlikely that
the changes could be ascribed to a generalised
Schwartzmann reaction.
Effect of heparin: Heparin treatment considerably de-
creased the severity of the thrombocytopenia occurring
in guinea pigs after moderate doses of Echis c%ratw
venom, but in no instance was it able to restore the platelet
count to normal. Heparin, also in larger amounts_ did not
prevent rapid haemorrhagic death after administration of
higher doses of venom. such as 200 - 400 /l-g. This is
ascribed to the action of a vessel wall-damaging agen!.'"
Heparin did not seem effective in Agkistrodon rhodosTOlIla
envenomation."
Supporting evidence for the production of venom-
induced incoagulability by intravascular clotting is obtained
by experiments with heparin. It was shown to be effective
both in preventing the afibrinogenaemia and in correcting
it when administered after the venom injection in experi-
mental envenomation with Russell's viper venom.'" Echis
carinatlls venom" and with Echis c%ratlls venom. 19,,·
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fig. 10. Baboon 12 received 1 mg venom with heparin immediately.
In our studies the baboons in experiments 5 and 6 both
received I mg of venom, but the second baboon also
immediately received a large dose of heparin, and his
clinical condition remained very satisfactory. There was
no evidence of shock and the mucous membrane haemorr-
hages and haematuria so prominent in the baboon without
heparin were completely absent. Both animals demon-
strated thrombocytopenia within 5 minutes, and platelets
remained low in the first baboon, whereas in the second
animal they returned to normal after 24 hours.
The single massive dose of heparin given simultaneously
with the venom appeared, on clinical evidence, to have a
beneficial effect.
CONCLUSION
The effect of puff-adder venom in the baboon appears to
be related to the dose. Venom in massive doses (5 mg or
more) leads to dramatic thrombocytopenia, delay in the
intrinsic clotting mechanism, fibrinolysis, fibrinogenolysis
in vitro and multiple haemorrhages with rapidly developing
shock. Heparin in large doses has no protective value and
is contra-indicated.
With smaller doses of venom (l mg or less) there is
evidence of consumption of the blood coagulation factors.
with platelet concentration still showing an initial moderate
fall. Heparin may be beneficial in these cases. and might
even have a direct effect on the platelets by preventing
aggregation. This effect of heparin should be further
investigated. It may have a place in treating mildly affected
cases where absorption into the blood has been slow. when
no antivenene is available, or the patients are sensitive to
serum.
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